Advertisement

The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization

  • Basil C. Tarlatzis
  • Grigoris Grimbizis
News And Views Controversies In Reproductive Medicine

Conclusions

It seems, therefore, that in PCOS patients stimulated for IVF with HMG, follicular-phase LH levels have an adverse effect on follicle and oocyte numbers as well as on oocyte quality. Moreover, an inappropriately raised LH appears to have a deleterious effect on the pregnancy outcome by being associated with a greater possibility for miscarriage. On the other hand, the administration of GnRH-a in the long desensitization protocol seems to reverse the detrimental effect of increased LH concentrations on follicular and oocyte development, whereas the beneficial effect on oocyte maturity, although significant, appears to be less profound. Furthermore, GnRH-a administration is associated with a decreased risk for early abortion.

Keywords

Luteinizing Hormone Clomiphene Citrate PCOS Patient Luteinizing Hormone Level PCOS Woman 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tarlatzis BC, Grimbizis G: Assisted reproduction techniques in polycystic ovarian syndrome. Ann NY Acad Sci 1993;687:280–287PubMedCrossRefGoogle Scholar
  2. 2.
    Meldrum DR: News and Views. J Assist Reprod Genet 1993;10:2–3CrossRefGoogle Scholar
  3. 3.
    Balen AH, Tan SL, Jacobs HS: Hypersecretion of luteinizing hormone: A significant cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082–1089PubMedGoogle Scholar
  4. 4.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S: The prognostic value of basal luteinizing hormone: Follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod 1995;10:2545–2549PubMedGoogle Scholar
  5. 5.
    Homburg R, Feldberg D, Berkowitz D, Ashkenazi J, Levy T, Ben-Rafael Z: In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993;60:858–863PubMedGoogle Scholar
  6. 6.
    Homburg R, Feldberg D, Levy T, Ashkenazi J, Berkowitz D, Ben-Rafael Z, Farchi J: Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 1993;59:527–531PubMedGoogle Scholar
  7. 7.
    Turhan NO, Artini PG, D’Ambrogio G, Groghini F, Battaglia C, Genazzani AD, Volpe A, Genazzani AR: A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. J Assist Reprod Genet 1993;10:15–20PubMedCrossRefGoogle Scholar
  8. 8.
    Owen JE, Davies MC, Kingsland CR, Jacobs HS, Mason BA: The use of a short regimen of buserelin, a gonadotropin-releasing hormone agonist and human menopausal gonadotropin in assisted conception cycles. Hum Reprod 1989;4:749–753PubMedGoogle Scholar
  9. 9.
    Schmutzler RK, Reichert C, Diedrich K, Wildt L, Diedrich Ch, Al-Hasani S, Van der Ven H, Krebs D: Combined GnRH-agonist/gonadotropin stimulation for in-vitro fertilization. Hum Reprod 1988;3 (Suppl 2):29–33PubMedGoogle Scholar
  10. 10.
    Dor J, Shulman A, Pariente C, Levran D, Bider D, Menashe Y, Mashiach S: The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: A prospective study. Fertil Steril 1992;57:366–371PubMedGoogle Scholar
  11. 11.
    Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshino K, Kitao M: Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Hum Reprod 1994;9:1231–1236PubMedGoogle Scholar
  12. 12.
    Lanzone A, Fulghesu AM, Spina MA, Apa R, Menini E, Caruso A, Mancuso A: Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987;65:1253–1258PubMedCrossRefGoogle Scholar
  13. 13.
    Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S: The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod 1990;5:816–818PubMedGoogle Scholar
  14. 14.
    Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal LH levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385–393PubMedGoogle Scholar
  15. 15.
    Howles CM, MacNamee MC, Edwards RG, Goswamy R, Steptoe PC: Effect of high tonic levels of luteinizing hormone on outcome of in vitro fertilization. Lancet 1986;2:521–523PubMedCrossRefGoogle Scholar
  16. 16.
    Watson H, Kiddy DS, Hamilton-Fairley D, Scanlon MJ, Barnard C, Collins WP, Bonney RC, Franks S: Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod 1993;8:829–833PubMedGoogle Scholar
  17. 17.
    Hofmann GE, Bergh PA, Guzman I, Masuku S, Navot D: Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod 1993;8:695–698PubMedGoogle Scholar
  18. 18.
    Bider D, Levran D, Mashiach S, Ben-Shlomo I, Dor J: Polycystic ovarian disease (PCOD)—Pregnancy rate and outcome in in vitro fertilization. J Assist Reprod Genet 1993;10:11–14PubMedCrossRefGoogle Scholar
  19. 19.
    Homburg R, Armar AN, Eshel A, Adams J, Jacobs HS: The influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in patients with polycystic ovary syndrome. Br Med J 1988;297:1024–1026CrossRefGoogle Scholar
  20. 20.
    Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S: Low dose gonadotropin therapy for induction of ovulation in 100 women with PCOS. Hum Reprod 1991;6:1095–1099PubMedGoogle Scholar
  21. 21.
    Johnson P, Pearce MJ: Recurrent spontaneous abortion and polycystic ovarian disease: Comparison of two regimens to induce ovulation. Br Med J 1990;300:154–156Google Scholar
  22. 22.
    Li TC, Serle E, Warren MA, Cooke ID: Is endometrial development in the periimplantation period influenced by high concentrations of luteinizing hormone in the follicular phase? Hum Reprod 1993;8:1021–1024PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Basil C. Tarlatzis
    • 1
    • 2
  • Grigoris Grimbizis
    • 1
    • 2
  1. 1.1st Department of Obstetrics & GynecologyAristotle UniversityGreece
  2. 2.Infertility & IVF Center, “Geniki Kliniki”ThessalonikiGreece

Personalised recommendations